Since Midatech Pharma Plc (NASDAQ:MTP) and Intec Pharma Ltd. (NASDAQ:NTEC) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affect the dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation of both companies.
Earnings and Valuation
We can see in table 1 the earnings per share (EPS), top-line revenue and valuation of Midatech Pharma Plc and Intec Pharma Ltd.
Table 2 demonstrates the net margins, return on assets and return on equity of Midatech Pharma Plc and Intec Pharma Ltd.
Insider and Institutional Ownership
Midatech Pharma Plc and Intec Pharma Ltd. has shares owned by institutional investors as follows: 0% and 39.64%. Midatech Pharma Plc’s share owned by insiders are 32.1%. Competitively, insiders own roughly 11.81% of Intec Pharma Ltd.’s shares.
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance